Zofran Heart Murmur

zofran_heart_murmurPregnant women who are prescribed Zofran to control nausea and vomiting in their first trimester may be more likely to give birth to a child with serious congenital abnormalities, including heart murmurs and other cardiac defects. A growing number of Zofran lawsuits claim that GlaxoSmithKline concealed the drug’s risks and failed to provide patients and doctors with adequate warnings regarding its alleged association with the development of major birth defects.

Zofran Heart Murmur Investigation

Bernstein Liebhard LLP, a nationwide law firm that represents the victims of serious drug side effects and complications, is investigating legal claims on behalf of children who may be suffering from a Zofran heart murmur. If your child was exposed to this medication during the first trimester of pregnancy and has been diagnosed with this condition, please call (888) 994-5118 to discuss your legal options with one of our attorneys.

Zofran Off-Label Use

Zofran (ondansetron) is a prescription medication approved to prevent nausea and vomiting in post-operative surgery patients, as well as individuals undergoing certain cancer treatments. Though it has never been approved to treat morning sickness or any form of pregnancy-related nausea and vomiting, a 2014 analysis entitled “Treating morning sickness in the United States—changes in prescribing are needed” reported that as many as 1 million pregnant women per year have been prescribed the drug for this off-label indication.

While doctors are able to prescribe approved drugs for any purpose they deem appropriate, pharmaceutical manufacturers are, in most cases, legally prohibited from marketing a medication based on an unapproved indication. In 2012, GlaxoSmithKline agreed to pay $3 billion to resolve federal drug marketing charges involving Zofran and a number of other medications. Among other things, the U.S. Department of Justice had accused Glaxo of improperly promoting Zofran as an off-label treatment for morning sickness. Read More

Zofran Birth Defects

Despite its widespread-off label use to treat pregnancy-related nausea and vomiting, Zofran’s effects on a developing pregnancy have not been well-studied. It’s placement by the U.S. Food & Drug Administration (FDA) in Pregnancy Category B is indicative of this fact. In recent years, a growing number of reports and studies have suggested that Zofran may be associated with an increased risk of major birth defects when taken by expectant mothers during the first trimester of pregnancy.

  • 2006: Hong Kong researchers examining 41 samples of fetal tissue taken from women who had been treated with Zofran in the first trimester reported that the drug’s active ingredient had been detected in every specimen, indicating that Zofran can cross the human placental barrier.
  • 2013: Researchers looking at 900,000 pregnancies included in a Danish health registry concluded that children born to women who took Zofran during the first trimester were 30% more likely to develop a major birth defect. Such children were also 2 times more likely to suffer serious cardiac malformations such as heart murmurs.
  • 2014: The Toronto Star revealed that in 2012, at least 20 Canadian women treated with ondansetron for nausea vomiting in pregnancy experienced serious side-effects, including two infant deaths and multiple cases of newborns with heart defects and kidney malformations. The newspaper’s analysis of FDA adverse event reports also uncovered instances of baby’s born with mouth deformities, heart murmurs, and atrial septal defect where ondansetron was the suspected cause.

What is a Heart Murmur?

A heart murmur is an unusual whooshing or swishing sound heard during a heartbeat. In an infant, symptoms may include:

  • Rapid breathing
  • Difficulty feeding
  • Blueness in the lips (cyanosis)
  • Failure to thrive

Adults who suffer from a heart murmur may experience fatigue, difficulty exercising or engaging in physical activity, and chest pain.

Sometimes, a heart murmur is the result of a congenital birth defect, such as a hole in the heart. In such cases, an infant may need to undergo surgery and other medical intervention to treat the underlying issue.

Zofran Litigation Update

Since February 2015, scores of plaintiffs have filed Zofran birth defects lawsuits in courts around the U.S. All such federal cases were centralized in a multidistrict litigation currently underway in the U.S. District Court, District of Massachusetts, by an Order of the U.S. Judicial Panel on Multidistrict Litigation dated October 13, 2015. Read More

Can I File a Zofran Heart Murmur Lawsuit?

You may be able to take legal action against GlaxoSmithKline if your baby was born with a heart murmur following first trimester exposure to Zofran. To arrange for a free, legal review of your case, please call (888) 994-5118.

  1. AJOG (2014) “Treating morning sickness in the United States—changes in prescribing are needed” http://www.ajog.org/article/S0002-9378%2814%2900853-9/abstract
  2. Clinical Phamokinetics (2006) “Placental transfer of ondansetron during early human pregnancy” http://www.ncbi.nlm.nih.gov/pubmed/16584287
  3. TDM Journal Club ( 2013) “Scary Science: Ondansetron Safety in Pregnancy—Two Opposing Results From the Same Danish Registry” http://www.helpher.org/blog/wp-content/uploads/2014/01/2014-Koren-Ondansetron-Safety-TDM.pdf
  4. The Toronto Star (2014) “Birth defects blamed on unapproved morning sickness treatment” http://www.thestar.com/news/gta/2014/06/25/birth_defects_blamed_on_unapproved_morning_sickness_treatment.html, the Toronto Star.com
Last Modified: January 6, 2016

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.

 
 
 

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest